FindTrial
Sign In

Hearing evaluation in COVID 19 recovered patients

Audiological status in post COVID 19 recovered patients - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/033943
Enrollment
96
Registered
2021-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Yenepoya Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects in the age group 18years to 50years who have recovered from COVID 19 infection who have either been treated or not with hydroxychloroquine

Exclusion criteria

Exclusion criteria: Age above 50 years Middle ear disease Individual who have past history of hearing loss Diabetes mellitus Genetic disorders of hearing Congenital ear abnormalities

Design outcomes

Primary

MeasureTime frame
Percentage of COVID 19 survivors with hearing loss. Degree of hearing loss in COVID 19 survivors with use of hydroxychloroquine or without use of hydroxychloroquine.Timepoint: 18 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR HARSH A SURI

Yenepoya Medical College

harshsuri92@gmail.com9886273009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026